November 29 | 2021
EU publishes an article about the successful finalization of 2cureX’s MicroCaT project.
Read more
November 25 | 2021
2cureX publishes interim report for the third quarter and first nine months of 2021
Read more
November 25 | 2021
2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021
Read more
November 24 | 2021
2cureX expands its Clinical Advisory Board with Professor Andrew Beggs, Queen Elizabeth Hospital Birmingham, UK
Read more
November 23 | 2021
2cureX holds a virtual live-session on the 26th of November 2021 to present and discuss the Interim report for the third quarter of 2021.
Read more
October 29 | 2021
Mangold Fondkommission AB published an updated Analyst Report on 2cureX
Read more
October 29 | 2021
2cureX – Banbrytande cancerbehandlingstest rullas ut – Mangold Insight Analys
Read more
October 15 | 2021
2cureX successfully completed the EU-project MicroCaT and received the final financial tranche of a 3,0 MEUR grant.
Read more
October 12 | 2021
2cureX provides commercial goals for 2022 at Live Strategy Update on the 12th of October 2021.
Read more
October 8 | 2021
2cureX provides a Live Strategy Update on the company’s product portfolio and commercialization strategy on the 12th of October 2021.
Read more
October 5 | 2021
2cureX signs distribution agreement with Labormed in Slovenia
Read more
September 28 | 2021
Specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain
Read more
August 26 | 2021
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2021
Read more
August 26 | 2021
2cureX publishes interim report for the second quarter and first half of 2021
Read more
August 20 | 2021
New development of the IndiTreat® technology allows prediction of response to anti-angiogenic drugs in colorectal cancer.
Read more
July 29 | 2021
2cureX appoints two internationally highly recognized oncologists as Clinical Advisors
Read more
July 19 | 2021
2cureX receives important ISO 13485:2016 certification
Read more
July 1 | 2021
2cureX and University Hospital of Hamburg-Eppendorf present IndiTreat data at ESMO GI for early-stage Pancreatic Cancer
Read more